{
    "pmcid": "10986514",
    "qa_pairs": {
        "How did the nanobody-based detection assay demonstrate its potential in diagnostics?": [
            "The assay could detect picomolar concentrations of the SARS-CoV-2 spike protein.",
            "The assay could detect nanomolar concentrations of the SARS-CoV-2 spike protein.",
            "The assay could detect micromolar concentrations of the SARS-CoV-2 spike protein.",
            "The assay could detect millimolar concentrations of the SARS-CoV-2 spike protein."
        ],
        "What are the advantages of using nanobodies over conventional antibodies in the context of SARS-CoV-2 neutralization?": [
            "Nanobodies have high stability, low production costs, and can be produced in bacterial systems.",
            "Nanobodies have a larger size, allowing for more complex binding interactions.",
            "Nanobodies are derived from human antibodies, reducing the risk of immune rejection.",
            "Nanobodies require complex mammalian cell systems for production, increasing their specificity."
        ],
        "What did Cryo-EM studies reveal about the multimodular nanobodies' interaction with the SARS-CoV-2 spike protein?": [
            "The multimodular nanobodies did not disrupt the prefusion conformation of the spike protein.",
            "The multimodular nanobodies caused significant disruption to the spike protein's prefusion conformation.",
            "The multimodular nanobodies altered the spike protein's postfusion conformation.",
            "The multimodular nanobodies enhanced the spike protein's fusion capability."
        ],
        "What was the impact of the E484K mutation on the binding affinity of engineered nanobodies?": [
            "The E484K mutation reduced binding affinity, leading to neutralization escape.",
            "The E484K mutation increased binding affinity, enhancing neutralization potency.",
            "The E484K mutation had no effect on binding affinity, maintaining neutralization potency.",
            "The E484K mutation completely abolished binding, preventing any neutralization."
        ],
        "Which specific nanobodies were utilized in the study for neutralizing wild-type SARS-CoV-2?": [
            "Ty1, H11-H4, MR17-K99Y, and VHH V",
            "Ty2, H12-H5, MR18-K100Y, and VHH W",
            "Ty3, H13-H6, MR19-K101Y, and VHH X",
            "Ty4, H14-H7, MR20-K102Y, and VHH Y"
        ]
    }
}